Madrigal Pharmaceuticals (MDGL) Non Operating Interest Expenses (2016 - 2026)
Madrigal Pharmaceuticals' Non Operating Interest Expenses came in at $7.94 million for Q2 2026, up 140.6% from $3.3 million a year earlier and up 1.5% from the prior quarter.
Powered by 
Analysis
Madrigal Pharmaceuticals (MDGL) Non Operating Interest Expenses (2016 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Madrigal Pharmaceuticals reported Non Operating Interest Expenses of $31.51 million, up 128.7% year-over-year; for FY2025, it came in at $22.31 million, up 52.1% from FY2024.
- Non Operating Interest Expenses has increased in each of the last three years, with a three-year compound annual growth rate of 77.9% (FY2022 to FY2025).
- Going back by year, Non Operating Interest Expenses was $14.67 million in FY2024 (+15.4%), $12.71 million in FY2023 (+220.7%) and $3.96 million in FY2022.
- The five-year range for quarterly Non Operating Interest Expenses is $780,000 (Q2 2022) to $8.3 million (Q4 2025).
- Year-over-year, Non Operating Interest Expenses has increased for four consecutive quarters, with growth averaging 60.8% over the last eight quarters.
- The fastest year-over-year change in Non Operating Interest Expenses over five years came in Q2 2023 (growth of 271.9%), and the weakest in Q1 2025 (a decline of 14.0%).
- Business Quant data shows MDGL's Non Operating Interest Expenses at $7.82 million (Q1 2026), $8.3 million (Q4 2025) and $7.45 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Madrigal Pharmaceuticals | 14.69 Bn | 10.94 Bn | - | 7.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.94 Mn |
| Mar 31, 2026 | 7.82 Mn |
| Dec 31, 2025 | 8.30 Mn |
| Sep 30, 2025 | 7.45 Mn |
| Jun 30, 2025 | 3.30 Mn |
| Mar 31, 2025 | 3.30 Mn |
| Dec 31, 2024 | 3.50 Mn |
| Sep 30, 2024 | 3.68 Mn |
| Jun 30, 2024 | 3.66 Mn |
| Mar 31, 2024 | 3.84 Mn |
| Dec 31, 2023 | 3.97 Mn |
| Sep 30, 2023 | 3.50 Mn |
| Jun 30, 2023 | 2.90 Mn |
| Mar 31, 2023 | 2.34 Mn |
| Dec 31, 2022 | 1.68 Mn |
| Sep 30, 2022 | 1.50 Mn |
| Jun 30, 2022 | 780,000.00 |
| Jun 30, 2016 | 238,000.00 |
| Mar 31, 2016 | 975,000.00 |
API Access
Madrigal Pharmaceuticals Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=MDGL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "MDGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=MDGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();